University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

Phase 2

Completed

Conditions: Substance Abuse
HIV Infections
HIV

Interventions: Drug: Oral Naltrexone
Drug: Naltrexone Implant
Behavioral: Group Drug Counseling Manual Driven

First Posted Date: 2010-04-12

Last Posted Date: 2018-11-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 200

Registration Number: NCT01101815

Locations: 🇷🇺
Botkin Infectious Disease Hospital, Leningrad, Russian Federation

Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland

Phase 3

Completed

Conditions: Amphetamine Dependence

Interventions: Drug: VIVITROL injection and VIVITROL Placebo Injection , 24 weeks

First Posted Date: 2010-04-09

Last Posted Date: 2018-03-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 100

Registration Number: NCT01100853

Locations: 🇮🇸
SAA National Center of Addiction Medicine, Vogur Hospital, Storhofda 45, Reykjavík, Iceland

Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis

Completed

Conditions: Interstitial Cystitis
Chronic Prostatitis

First Posted Date: 2010-04-02

Last Posted Date: 2023-08-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 424

Registration Number: NCT01098279

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States

and more 5 locations

Efficacy of Varenicline for Smokeless Tobacco Use in India

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Drug: Varenicline
Behavioral: Counseling

First Posted Date: 2010-04-02

Last Posted Date: 2015-07-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 237

Registration Number: NCT01098305

Locations: 🇮🇳
All India Institute of Medical Research, New Dehli, India

Integrating Depression Services Into DM Management

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus
Depression

Interventions: Behavioral: Adherence Intervention

First Posted Date: 2010-04-02

Last Posted Date: 2012-03-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 182

Registration Number: NCT01098253

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Observational Study of Control Participants for the MAPP Research Network

Completed

Conditions: Fibromyalgia
Fatigue Syndrome, Chronic
Irritable Bowel Syndrome

First Posted Date: 2010-04-02

Last Posted Date: 2014-12-10

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 615

Registration Number: NCT01098292

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Stanford University, Stanford, California, United States

and more 5 locations

Rhodiola Rosea Therapy of Major Depressive Disorder

Phase 3

Completed

Conditions: Depression

Interventions: Dietary Supplement: Herbal extract
Other: Lactose monohydrate
Drug: Sertraline

First Posted Date: 2010-04-02

Last Posted Date: 2018-02-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 58

Registration Number: NCT01098318

Locations: 🇺🇸
Depression Research Unit, Philadelphia, Pennsylvania, United States

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis

Not Applicable

Completed

Conditions: Systemic Sclerosis
Scleroderma

Interventions: Drug: Ambrisentan

First Posted Date: 2010-03-26

Last Posted Date: 2018-11-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 15

Registration Number: NCT01093885

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Long Term Chamomile Therapy for Anxiety

Phase 3

Completed

Conditions: Generalized Anxiety Disorder

Interventions: Drug: Chamomile (Matricaria recutita)

First Posted Date: 2010-02-22

Last Posted Date: 2017-07-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 180

Registration Number: NCT01072344

Locations: 🇺🇸
Depression Research Unit, Philadelphia, Pennsylvania, United States

Behavioral Economics and Food Choice

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Behavioral: Calorie information
Behavioral: Exercise Equivalent only
Behavioral: Calorie & Exercise equivalent information

First Posted Date: 2010-02-03

Last Posted Date: 2011-11-16

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 4

Registration Number: NCT01061905

Locations: 🇺🇸
ARAMARK healthcare at Main Line Health, Bryn Mawr, Pennsylvania, United States
🇺🇸
ARAMARK Healthcare at Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸
ARAMARK healthcare at North Shore University Health System, Evanston, Illinois, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy